gimatecan (ST1481)

gimatecan · Lee's Pharmaceutical Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gimatecan (ST1481), covering 2020-10-01 to 2020-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]